Considerations for observational research using large data sets in radiation oncology

R Jagsi, JE Bekelman, A Chen, RC Chen… - International Journal of …, 2014 - Elsevier
The radiation oncology community has witnessed growing interest in observational research
conducted using large-scale data sources such as registries and claims-based data sets …

The Hallmarks of Predictive Oncology

A Singhal, X Zhao, P Wall, E So, G Calderini… - Cancer …, 2025 - aacrjournals.org
The rapid evolution of machine learning has led to a proliferation of sophisticated models for
predicting therapeutic responses in cancer. While many of these show promise in research …

[HTML][HTML] Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States

P Jain, JG Bugarin, A Guha, C Jain, N Patil, T Shen… - ESMO open, 2021 - Elsevier
Background Immune checkpoint inhibitors (ICIs) can cause life-threatening cardiovascular
adverse events (CVAEs) that may not be attributed to therapy. The outcomes of clinical trials …

Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data

J Beyrer, J Manjelievskaia, M Bonafede… - … and Drug Safety, 2021 - Wiley Online Library
Abstract Purpose An International Classification of Disease (ICD‐10) Charlson Comorbidity
Index (CCI) adaptation had not been previously developed and validated for United States …

Accuracy of administrative databases in detecting primary breast cancer diagnoses: a systematic review

I Abraha, A Montedori, D Serraino, M Orso… - BMJ open, 2018 - bmjopen.bmj.com
Objective To define the accuracy of administrative datasets to identify primary diagnoses of
breast cancer based on the International Classification of Diseases (ICD) 9th or 10th …

Group O RBC s: where is universal donor blood being used

RL Barty, M Pai, Y Liu, DM Arnold, RJ Cook… - Vox …, 2017 - Wiley Online Library
Background There have been recurrent shortages of group O blood due to insufficient
inventory and use of group O blood in ABO non‐identical recipients. We performed a 12 …

Validation of a case-finding algorithm for identifying patients with non-small cell lung cancer (NSCLC) in administrative claims databases

RM Turner, YW Chen, AW Fernandes - Frontiers in Pharmacology, 2017 - frontiersin.org
Objective: To assess the validity of a treatments-and tests-based Case-Finding Algorithm for
identifying patients with non-small cell lung cancer (NSCLC) from claims databases. Data …

Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry

A Palmaro, M Gauthier, C Conte, P Grosclaude… - Medicine, 2017 - journals.lww.com
Identifying multiple myeloma patients using data from the Fr... : Medicine Identifying multiple
myeloma patients using data from the French health insurance databases: Validation using a …

The value of a health insurance database to conduct pharmacoepidemiological studies in oncology

C Conte, C Vaysse, P Bosco, P Noize… - Therapies, 2019 - Elsevier
Some concerns have emerged about the evidence of benefits on survival outcomes or
quality of life of new anticancer drugs. In parallel, the decreased cancer mortality leads to an …

Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data

KA Oppelt, S Luttmann, K Kraywinkel… - BMC Medical Research …, 2019 - Springer
Background Incidence rates of advanced cancer stages are important, eg, for monitoring
cancer screening programs. However, information from cancer registries on tumor stage is …